In a study that might enable earlier diagnosis, neuroscientists find abnormal brain connections that can predict onset of psychotic episodes.
Electrons show chemists how to see more with less.
Pfizer's Susan Silbermann explains the superhuman effort involved in getting vaccines to the people who need them most.
Pfizer's partnerships strengthen their ability to deliver vaccines in developing countries.
Is microdosing magic truffles a way to unlock your creative potential? That's long been anecdotal, but the evidence is coming.
How psilocybin evolved has more to do with sending insects on terrifying trips than it does making Phish sound good.
Tiny and efficient, these biodegradable single cells show promise as a way to target hard-to-reach cancers.
Some opioid addicts are flying outside of the U.S. for addiction treatment using the psychedelic drug ibogaine. It has yet to be studied comprehensively, and it comes with its own set of risks.
With the approval of a childhood epilepsy medication the federal government can no longer claim marijuana has no medical benefit.
Achieving good health and well-being around the world is critical to the company's mission
Scientists in Japan have genetically modified chickens to lay eggs containing an extremely valuable protein that helps treat cancer, hepatitis and multiple sclerosis in humans. The cost of one of […]
Quarantines are worth the trouble to keep the next pandemic at bay but they need to be applied intelligently.
How does Alzheimer's disease work?
Homeopathic manufacturers take advantage of sick and vulnerable populations in criminal ways—and the FDA is, after much absence, starting to crack down.
Researchers are studying the use of sperm cells as micromotors for delivering chemotherapy to cervical cancer patients.
The case of a 7-year-old Australian boy who was supposed to lose sight at two weeks old but can still see has stunned scientists.
Despite doubts from the healthcare industry, Watson recently identified a surprisingly high number of potential cancer treatments for real-life patients.
Hertz Foundation Fellow Dr. Christopher Loose sold his first startup for $80 million. His advice is probably the kind you want to hear.
The most influential contemporary scientists and their accomplishments.
One researcher called it “the ultimate in the miniaturization of machinery.”
New research by Professor Dan Graur shows that only a quarter of the human genome is functional.
Scientists successfully test an ingenious system for growing premature fetuses.
Studies and trials point to the potential of a rave drug becoming the newest antidepressant medication in decades.